Nimacimab (Anti-CB1 / CNR1)

Ask supplier a question | View on supplier's website

Nimacimab (Anti-CB1/CNR1) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2574
Sku #	A2574-1mg*5
Pricing	1mg*5, $790.00

Feedback